However, since other TRIM molecules mentioned in our study, except for TRIM34 and TRIM5, have already been validated in glioma in vitro experiments from previous studies [23, 53–55], we focused our investigations on TRIM34 and TRIM5. This evidence concerns the gene TRAT1 and glioma.